The Increased Expression of TREM-1 on Monocytes Is Associated With Infectious and Noninfectious Inflammatory Processes

Journal of Surgical Research

Volumn 150, Issue 1, 2008, Pages 110-117

  Ferat Osorio, Eduardo ^a   Esquivel Callejas, Noemí ^a   Wong Baeza, Isabel ^a,b   Aduna Vicente, Rosalía ^a,b   Arriaga Pizano, Lourdes ^a   Sánchez Fernández, Patricio ^a   Torres González, Rubén ^c   López Macías, Constantino ^a   Isibasi, Armando ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

CARS; sepsis; SIRS; TREM 1

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SURGICAL TECHNIQUE;

ADULT; CASE-CONTROL STUDIES; GENE EXPRESSION; GENES, MHC CLASS II; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MONOCYTES; POSTOPERATIVE COMPLICATIONS; RECEPTORS, IMMUNOLOGIC; SEPSIS;

EID: 53449091692     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.12.805     Document Type: Article

References (31)

1. Nystrom P.O. The systemic inflammatory response syndrome: Definitions and etiology. J Antimicrob Chemother 41 Suppl A (1998) 1
2. Angele M.K., and Faist E. Clinical review: Immunodepression in the surgical patient and increased susceptibility to infection. Crit Care 6 (2002) 298
3. Takahashi H., Tsuda Y., Kobayashi M., et al. CCL2 as a trigger of manifestations of compensatory anti-inflammatory response syndrome in mice with severe systemic inflammatory response syndrome. J Leukoc Biol 79 (2006) 789
4. Volk H.D. Immunodepression in the surgical patient and increased susceptibility to infection. Crit Care 6 (2002) 279
5. Wolk K., Kunz S., Crompton N.E., et al. Multiple mechanisms of reduced major histocompatibility complex class II expression in endotoxin tolerance. J Biol Chem 278 (2003) 18030
6. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004) 858
7. Marshall J.C. Biomarkers of sepsis. Curr Infect Dis Rep 8 (2006) 351
8. Meisner M. Biomarkers of sepsis: Clinically useful?. Curr Opin Crit Care 11 (2005) 473
9. Bouchon A., Dietrich J., and Colonna M. Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164 (2000) 4991
10. Bouchon A., Facchetti F., Weigand M.A., et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410 (2001) 1103
11. Gonzalez-Roldan N., Ferat-Osorio E., Aduna-Vicente R., et al. Expression of triggering receptor on myeloid cell 1 and histocompatibility complex molecules in sepsis and major abdominal surgery. World J Gastroenterol 11 (2005) 7473
12. Wang D.Y., Qin R.Y., Liu Z.R., et al. Expression of TREM-1 mRNA in acute pancreatitis. World J Gastroenterol 10 (2004) 2744
13. Aoki N., Zganiacz A., Margetts P., et al. Differential regulation of DAP12 and molecules associated with DAP12 during host responses to mycobacterial infection. Infect Immunol 72 (2004) 2477
14. El Mezayen R., El Gazzar M., Seeds M.C., et al. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett 111 (2007) 36
15. Wong-Baeza I., Gonzalez-Roldan N., Ferat-Osorio E., et al. Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clin Exp Immunol 145 (2006) 448
16. Bleharski J.R., Kiessler V., Buonsanti C., et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 170 (2003) 3812
17. Gibot S., Massin F., Le Renard P., et al. Surface and soluble triggering receptor expressed on myeloid cells-1: Expression patterns in murine sepsis. Crit Care Med 33 (2005) 1787
18. Gibot S., Kolopp-Sarda M.N., Bene M.C., et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 200 (2004) 1419
19. Gibot S., Kolopp-Sarda M.N., Bene M.C., et al. Plasma level of a triggering receptor expressed on myeloid cells-1: Its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 141 (2004) 9
20. Gibot S., Cravoisy A., Levy B., et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 350 (2004) 451
21. Gibot S., Cravoisy A., Dupays R., et al. Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis. Scand J Infect Dis 39 (2007) 604
22. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864
23. Gibot S., Le Renard P.E., Bollaert P.E., et al. Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med 31 (2005) 594
24. de Metz J., Romijn J.A., Endert E., et al. Interferon-gamma increases monocyte HLA-DR expression without effects on glucose and fat metabolism in postoperative patients. J Appl Physiol 96 (2004) 597
25. Kawasaki T., Ogata M., Kawasaki C., et al. Surgical stress induces endotoxin hyporesponsiveness and an early decrease of monocyte mCD14 and HLA-DR expression during surgery. Anesth Analg 92 (2001) 1322
26. Bianchi M.E. DAMPs PAM. Ps and alarmins: all we need to know about danger. J Leukoc Biol 81 (2007) 1
27. Gibot S., Cravoisy A., Kolopp-Sarda M.N., et al. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 33 (2005) 792
28. Ho Y.P., Sheen I.S., Chiu C.T., et al. A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitis. Am J Gastroenterol 101 (2006) 1117
29. Oczenski W., Krenn H., Jilch R., et al. HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery. Intensive Care Med 29 (2003) 1253
30. Lendemans S., Kreuzfelder E., Waydhas C., et al. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma. Inflamm Res 56 (2007) 38
31. Borgermann J., Friedrich I., Scheubel R., et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass. Thorac Cardiovasc Surg 55 (2007) 24